Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC

BACKGROUND: The development of drug resistance and high mortality rates are the major problems observed in non-small cell lung cancer (NSCLC). Biomarkers indicating and predicting disease development towards these unfavorable directions are therefore on high demand. Many studies have demonstrated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Simiene, Julija, Dabkeviciene, Daiva, Stanciute, Diana, Prokarenkaite, Rimvile, Jablonskiene, Valerija, Askinis, Renatas, Normantaite, Kamile, Cicenas, Saulius, Suziedelis, Kestutis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496384/
https://www.ncbi.nlm.nih.gov/pubmed/37697308
http://dx.doi.org/10.1186/s12885-023-11365-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496384/
https://www.ncbi.nlm.nih.gov/pubmed/37697308
http://dx.doi.org/10.1186/s12885-023-11365-5

Ejemplares similares